Tagged with diagnostics,

Luxembourg Miriam Steimer, as employee number one of the Fast-track diagnostics success story, provides a thorough analysis into the company’s global footprint, the scope of operations in Luxembourg with both manufacturing and R&D activities, and the significance of the “made in Luxembourg” label. Finally, Ms Steimer shares FTD’s remarkably high levels…

Singapore The founder and CEO of Vela Diagnostics, Michael Tillmann underscores the motivating drivers behind the establishment of the company and how their unique portfolio of automated PCR and NGS solutions have made clinical laboratory life easier for all companies across the molecular diagnostics value chain. He further highlights the crucial…

Pharma GE Healthcare Italy’s Marco Campione discusses patient access to innovation, synergies between pharma and medtech in companion diagnostics, and partnering with the Italian healthcare system. You have been working at GE Healthcare for 18 years now, having risen up the ranks through various departments. What was at the top of…

Pharma Jean-Luc Bélingard, chairman of bioMérieux, reveals how the medical community in France has a unique profile, combining both clinical and technological experience, leading to what he describes as the best healthcare system in the world from a pure patient perspective; why diagnostics is the bedrock of an efficient healthcare system;…

Pharma Arnaud Pradel, Product Development Director and Co-Segment Leader of HORIBA Medical reveals how HORIBA has over 30 years of experience when it comes to launching products in the vitro diagnostic space, and in managing distributors in over 130 countries; why historically there has been a close relationship between the global…

Pharma Mr. Michel Finance, CEO of Theradiag, a leading French player in in vitro diagnostics and the novel field of theranostics (a combination of treatment and diagnosis), discusses the major restructuring at Theradiag he oversaw, the crucial role that diagnostics play in the provision of efficient as well as cost-effective healthcare…

pharma The country manager of Roche Diagnostics SA, Rajen Bhimaraj highlights the current gaps in the country’s healthcare system and elaborates on how the company’s various community initiatives, such as AmpliCare and the Roche Scientific Campus, are helping to address those gaps. He also evaluates the role of diagnostics in tackling…

pharma Thomas Würdinger, winner of the 2014 Galenus prize, discusses his research team’s efforts to developing new treatment options and protocols for brain cancers, and the need for greater attention and investment in brain cancer treatment development, an area he identifies as the greatest unmet medical need in the field of…

Pharma The CEO of Diaxonhit Group, a fully integrated French leader in in vitro diagnostics, discusses the company’s strategic focus on specialty vitro diagnostics, his perspective on the challenge of consolidation that the diagnostics industry faces, as well as his cautiously optimistic assessment of  French competitiveness in the pharmaceutical and life…

diagnostics In 2014, Hari Sabnani moved from Cardinal Health’s Puerto Rican affiliate to take the helm of Quest Diagnostics Puerto Rico, the country’s largest clinical lab. He discusses the change in position and emphasizes the importance of ensuring that equipment is being used to its fullest potential in a time of…

distribution José Antonio Crespo became general manager for Beckman Coulter Iberia in July 2013, following an extensive career at Siemens. He discusses the structural changes associated with the company’s acquisition by Danaher, and outlines targets for growth in the coming years.   What initial challenges did you face at the beginning…

diagnostics Life Length was founded through the CNIO (Spanish National Cancer Research Center) combined with the support of the Botín Foundation, Matlin Associates and Dr. Maria Blasco’s work in telomeres. Stephen J. Matlin, CEO of Life Length, discusses the potential of the company’s diagnostic test to become a standard biomarker for…